Ptc Therapeutics, Inc. Earnings

Ptc Therapeutics, Inc.’s revenue fell -30.58% since last year same period to $213.17Mn in the Q4 2024. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated 8.33% jump in its revenue since last 3-months.

Ptc Therapeutics, Inc.’s net profit jumped 57.71% since last year same period to $-65.89Mn in the Q4 2024. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated 38.22% jump in its net profits since last 3-months.

Ptc Therapeutics, Inc.’s net profit margin jumped 39.08% since last year same period to -30.91% in the Q4 2024. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated 42.97% jump in its net profit margins since last 3-months.

Ptc Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.65 - a 54.86% jump from last quarter’s estimates.

Ptc Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.65.

Ptc Therapeutics, Inc.’s earning per share (EPS) fell -42.33% since last year same period to -0.34 in the Q4 2024. This indicates that the Ptc Therapeutics, Inc. has generated -42.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.